Dr. Charles Kilo, MD (he/him) is an Endocrinologist in Naples, FL with over 17 years of experience. What is your opinion of Dr. Charles Kilo, MD? Rate this provider below so other people can make informed decision.
Over 17 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Charles Kilo, MD has received over $374,559 which includes payments from the following companies:
$323,496.07 from Janssen Pharmaceuticals, Inc
$13,875.62 from Boehringer Ingelheim Pharmaceuticals, Inc.
$9,956.29 from sanofi-aventis U.S. LLC
$5,626.42 from LILLY USA, LLC
$4,728.60 from Novo Nordisk Inc
$2,779.73 from AstraZeneca Pharmaceuticals LP
$2,572.91 from MannKind Corporation
$1,825.68 from GlaxoSmithKline, LLC.
$1,526.66 from Merck Sharp & Dohme Corporation
$1,018.83 from Amgen Inc.
$620.49 from Amarin Pharma Inc.
$526.76 from Astellas Pharma US Inc
$467.51 from Pfizer Inc.
$396.06 from Arbor Pharmaceuticals, Inc.
$343.30 from AbbVie, Inc.
$311.67 from Takeda Pharmaceuticals U.S.A., Inc.
$299.91 from Kowa Pharmaceuticals America, Inc.
$282.72 from Novartis Pharmaceuticals Corporation
$271.41 from Abbott Laboratories
$255.34 from Iroko Pharmaceuticals, LLC
Payments received by Dr. Charles Kilo, MD were from the following categories:
$280,941.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!